Characterization of the cellular transport mechanisms for the anti‐cachexia candidate compound TCMCB07
Author:
Affiliation:
1. Department of Pharmaceutical Sciences, College of Pharmacy University of Michigan Ann Arbor MI USA
2. Tensive Controls, Inc. Columbia MO USA
Funder
National Institutes of Health National Cancer Institute
Publisher
Wiley
Subject
Physiology (medical),Orthopedics and Sports Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcsm.12602
Reference50 articles.
1. Treatment of cachexia: An overview of recent developments
2. Novel targeted therapies for cancer cachexia
3. Cancer-associated cachexia
4. Advances in pharmacologic strategies for cancer cachexia
5. Drugs of Muscle Wasting and Their Therapeutic Targets
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Characteristics of membrane transport, metabolism, and target protein binding of cyclic depsipeptide destruxin E in HeLa cells;Drug Metabolism and Pharmacokinetics;2024-10
2. Safety of TCMCB07, a melanocortin‐4 antagonist peptide, in dogs with naturally occurring cachexia;Journal of Veterinary Internal Medicine;2023-10-28
3. Development of a Therapeutic Peptide for Cachexia Suggests a Platform Approach for Drug-like Peptides;ACS Pharmacology & Translational Science;2022-04-14
4. Pharmacokinetics and safety of TCMCB07, a melanocortin‐4 antagonist peptide in dogs;Pharmacology Research & Perspectives;2021-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3